Claria Vision emerged from a deeply personal mission: to preserve human connection when memory fades. Our story begins with family, continues with breakthrough science, and aims to transform how we care for those we love most.
When Dr. Sarah Chen watched her grandmother struggle to recognize family members, she witnessed the profound pain that Alzheimer's brings to both patients and loved ones. As an AI researcher at Stanford, she knew technology could help—but only if designed with dignity and humanity at its core.
Partnering with Dr. Michael Rodriguez, a geriatrician who had spent decades advocating for patient-centered care, they founded Claria Vision in 2022 with a simple belief: technology should enhance human connection, never replace it.
"Every line of code we write, every design decision we make, is guided by one question: Does this honor the dignity of the person wearing it?"
Our diverse leadership combines deep technical expertise with compassionate healthcare experience, united by a shared commitment to dignity-first innovation.
Co-Founder & CEO
PhD in AI/ML from Stanford. Former Google Research scientist specializing in computer vision and ethical AI. Personal experience as Alzheimer's caregiver.
Co-Founder & CMO
MD from UCSF, specializing in geriatric medicine. 20+ years in memory care, advocate for patient-centered technology in healthcare settings.
Chief Technology Officer
Former Apple AR/VR lead engineer. Expert in edge computing and privacy-preserving AI systems. Passionate about accessible technology design.
VP Clinical Affairs
PhD in Clinical Psychology, specializing in cognitive assessment and assistive technology. Former Mayo Clinic researcher in Alzheimer's care.
VP Design & Accessibility
Former IDEO design lead specializing in inclusive design for aging populations. Expert in cognitive accessibility and assistive technology UX.
VP Operations
Former Medtronic operations executive with expertise in medical device manufacturing and FDA regulatory pathways. Healthcare compliance specialist.
World-renowned experts in Alzheimer's research, AI ethics, and healthcare technology guide our development and ensure clinical excellence.
Johns Hopkins Memory Center
Leading Alzheimer's researcher, 200+ publications
Mayo Clinic Neurology
Geriatric neurologist, assistive technology pioneer
UCSF Memory & Aging Center
Clinical trials specialist, patient advocacy leader
MIT AI Ethics Lab
AI ethics pioneer, privacy-preserving ML expert
Former Google Research
Computer vision specialist, YOLO architecture contributor
Stanford HCI Lab
Accessibility technology researcher, AR/VR specialist
Every decision we make is guided by principles that put human dignity, family connection, and patient autonomy at the center of innovation.
Every feature we build must enhance patient autonomy and self-respect. Technology should empower, never diminish, the human experience.
Personal data stays personal. Edge processing and encrypted connections ensure family moments remain private and secure.
We design for diverse cognitive abilities, cultural backgrounds, and family structures. Good technology works for everyone.
Clinical research guides every development decision. We measure success through improved patient outcomes and family well-being.
Families deserve honest updates about development milestones, challenges, and timelines. Trust requires transparency.
We build for long-term accessibility and affordability, ensuring breakthrough technology reaches all families who need it.
From personal inspiration to clinical validation, every milestone brings us closer to transforming Alzheimer's care.
Dr. Chen and Dr. Rodriguez establish Claria Vision with seed funding from Stanford StartX
Initial smart glasses prototype achieves 95% recognition accuracy in controlled testing
$12M Series A led by Andreessen Horowitz, with participation from GV and Khosla Ventures
Phase II trials launch with Johns Hopkins and Mayo Clinic, 156 participants enrolled
Received FDA Breakthrough Device Designation, accelerating regulatory pathway
Limited early access program launches with 2,300+ families on waitlist
Industry recognition validates our commitment to ethical innovation and breakthrough healthcare technology.
MIT Technology Review
Partnership on AI
Fast Company
National Federation of the Blind
While our heart remains with Alzheimer's care, we envision a future where assistive AI technology supports all forms of cognitive challenges, from traumatic brain injury to age-related memory changes.
AI assistance for various memory and recognition challenges
Affordable technology reaching underserved communities worldwide
Early detection and intervention for cognitive health
Whether you're a healthcare professional, researcher, investor, or family member, there's a place for you in building the future of compassionate technology.